PeptiStrong® Receives FDA GRAS Approval for Food Applications

CONNECTICUT, UNITED STATES, December 3, 2024 – Nuritas, a global leader in AI-driven peptide ingredients, proudly announces that the U.S. Food and Drug Administration (FDA) has issued a Letter of No Objection regarding the Generally Recognized as Safe (GRAS) status of its flagship muscle health ingredient, PeptiStrong®.

PeptiStrong® is a natural ingredient derived from fava bean protein containing a proprietary blend of precision peptides that are clinically proven to preserve your body’s strength and boost its ability to recover so you can be your best self, longer.

The FDA’s letter confirms that PeptiStrong® is safe for use at a level of 2.4g per serving across a broad range of popular food applications, including dry-blend powders, meal replacement drinks and bars, milk analogs, ready-to-drink beverages, gummies, protein and energy bars, baked goods, and more. This approval creates new opportunities for PeptiStrong® in the rapidly growing health and wellness industry.

“We’re thrilled by this acknowledgement, as it further expands our access to an even larger customer base,” said Nuritas CCO Chris Lindsay. “PeptiStrong® is already widely used by many fantastic partners worldwide. This confirmation will further accelerate our penetration with large multinational CPG companies.”

Multiple clinical trials have demonstrated its ability to enhance muscle mass, strength, recovery, and energy while reducing exercise-induced inflammation. These benefits make PeptiStrong® ideal for sports nutrition, active lifestyles, and overall health.

Nuritas CEO Dr. Nora Khaldi said “Food is the main vehicle that gives everyday consumers access to nutrition and performance. We have built both robust safety and clinical data for PeptiStrong®, our plant-based peptide ingredient, which allows it to become a staple component in a wide range of foods. Incorporating PeptiStrong® into our diets helps give lasting energy throughout the day and enhances the nutritional effectiveness of protein, even in small amounts. This supports lean muscle mass maintenance, helping people live stronger for longer.”

Dr. Khaldi added “Building and retaining muscle mass is essential for everyone. Studies show that increasing muscle mass can help reduce all-cause mortality and significantly improve quality of life.”

Nuritas leverages cutting-edge artificial intelligence to discover and unlock the potential of precision peptides, providing sustainable and effective solutions for a variety of health challenges. The GRAS approval for PeptiStrong® underscores Nuritas’ unwavering commitment to improving global health through innovative science.

For more information about PeptiStrong® or to schedule an interview with our team, please contact:

For media inquiries:
Nuritas Communications Team
Email: [email protected]
Phone: +353-1-234-5678
Website: www.nuritas.com